Stephen Rees

Steve Rees is currently Vice-President of Screening Sciences and Sample Management at AstraZeneca with global responsibility for High Throughput Screening, Compound Management, the human tissue BioBank and the provision of SAR biology support to preclinical discovery projects. Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles including that of Director of the Screening and Compound Profiling Department. Steve is responsible for developing hit identification, compound profiling, sample management and open innovation strategies for AstraZenenca. Steve has led multiple international collaborations, has authored >60 scientific papers and has spoken at many international symposia. He is Chair of the SLAS Europe Council, a member of the BBSRC panel of experts and is a member of the Board of Directors of ELRIG.